Clinical trial NCT00382161 - References

Impotence — Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors

Citation(s)

•   Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A
  Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf). 2003 May;58(5):632-8.
•   Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U
  Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res. 2000 Dec;12(6):305-11.
•   Büyükafsar K, Un I
  Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice. Eur J Pharmacol. 2003 Jul 11;472(3):235-8.
•   Chitaley K, Wingard CJ, Clinton Webb R, Branam H, Stopper VS, Lewis RW, Mills TM
  Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med. 2001 Jan;7(1):119-22.
•   Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB
  Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994 Jan;151(1):54-61.
•   Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, Elmer PJ
  Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension. 1997 Jan;29(1 Pt 1):8-14.
•   Impotence
  NIH Consens Statement. 1992 Dec 7-9;10(4):1-33. Review.
•   Kinsey AC, Pomeroy W, Martin CE
  Sexual behavior in the human man. 1948:218-262
•   Laufs U, Wassmann S, Hilgers S, Ribaudo N, Böhm M, Nickenig G
  Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol. 2001 Dec 1;88(11):1306-7.
•   Nangle MR, Cotter MA, Cameron NE
  Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering. Diabetes. 2003 Sep;52(9):2396-402.
•   Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM
  Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999 Dec;11(6):319-26.
•   Speel TG, van Langen H, Wijkstra H, Meuleman EJ
  Penile duplex pharmaco-ultrasonography revisited: revalidation of the parameters of the cavernous arterial response. J Urol. 2003 Jan;169(1):216-20.
•   Virag R, Bouilly P, Frydman D
  Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet. 1985 Jan 26;1(8422):181-4.
•   Wassmann S, Ribaudo N, Faul A, Laufs U, Böhm M, Nickenig G
  Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl. Am J Cardiol. 2004 Jan 1;93(1):84-8.
•   Wei M, Macera CA, Davis DR, Hornung CA, Nankin HR, Blair SN
  Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol. 1994 Nov 15;140(10):930-7.

Influence of Treatment With the HMG-CoA-Reductase Inhibitor Fluvastatin on Erectile Function in Patients With Cardiovascular Risk-Factors and Erectile Dysfunction

Details for clinical trial NCT00382161